Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis

PM and R

Volumn 8, Issue 4, 2016, Pages 356-366

  Wagle Shukla, Aparna ^a   Shuster, Jonathan J ^a   Chung, Jae Woo ^a   Vaillancourt, David E ^a,b   Patten, Carolynn ^a   Ostrem, Jill ^c   Okun, Michael S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Department of Applied Physiology and Kinesiology ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKINESIA; DISEASE SEVERITY; FOLLOW UP; GAIT; HUMAN; LEVODOPA-INDUCED DYSKINESIA; META ANALYSIS; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

HUMANS; MOTOR ACTIVITY; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84949675972     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2015.08.009     Document Type: Review

References (52)

1. Olanow C.W., Stern M.B., Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009, 72(21 Suppl 4):S1-S136.
2. Miyasaki J.M., Martin W., Suchowersky O., Weiner W.J., Lang A.E. Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2002, 58:11-17.
3. Okun M.S., Gallo B.V., Mandybur G., Jagid J., Foote K.D., Revilla F.J., et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: An open-label randomised controlled trial. Lancet Neurol 2012, 11:140-149.
4. Wagle Shukla A., Okun M.S. Surgicaltreatment of Parkinson's disease: Patients, targets, devices, and approaches. Neurotherapeutics 2014, 11:47-59.
5. Wagle Shukla A., Vaillancourt D.E. Treatment and physiology in Parkinson's disease and dystonia: Using transcranial magnetic stimulation to uncover the mechanisms of action. Curr Neurol Neurosci Rep 2014, 14:449.
6. Pascual-Leone A., Valls-Sole J., Wassermann E.M., Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 1994, 117(Pt 4):847-858.
7. Chen R., Classen J., Gerloff C., Celnik P., Wassermann E.M., Hallett M., et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997, 48:1398-1403.
8. Fregni F., Simon D.K., Wu A., Pascual-Leone A. Non-invasive brain stimulation for Parkinson's disease: A systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 2005, 76:1614-1623.
9. Elahi B., Elahi B., Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials. Mov Disord 2009, 24:357-363.
10. Benninger D.H., Berman B.D., Houdayer E., Pal N., Luckenbaugh D.A., Schneider L., et al. Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology 2011, 76:601-609.
11. Shirota Y., Ohtsu H., Hamada M., Enomoto H., Ugawa Y. Research Committee on rTMS Treatment of Parkinson's Disease. Supplementary motor area stimulation for Parkinson disease: A randomized controlled study. Neurology 2013, 80:1400-1405.
12. Boylan L.S., Pullman S.L., Lisanby S.H., Spicknall K.E., Sackeim H.A. Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinson's disease. Clin Neurophysiol 2001, 112:259-264.
13. Dias A.E., Barbosa E.R., Coracini K., Maia F., Marcolin M.A., Fregni F. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease. Acta Neurol Scand 2006, 113:92-99.
14. Epstein C.M., Davey K.R. Iron-core coils for transcranial magnetic stimulation. J Clin Neurophysiol 2002, 19:376-381.
15. Hamada M., Ugawa Y., Tsuji S. Effectiveness of rTMS on Parkinson's Disease Study Group, Japan. High-frequency rTMS over the supplementary motor area improves bradykinesia in Parkinson's disease: Subanalysis of double-blind sham-controlled study. J Neurol Sci 2009, 287:143-146.
16. Kimura H., Kurimura M., Kurokawa K., Nagaoka U., Arawaka S., Wada M., et al. A comprehensive study of repetitive transcranial magnetic stimulation in Parkinson's disease. ISRN Neurol 2011, 2011:845453.
17. Boggio P.S., Fregni F., Bermpohl F., Mansur C.G., Rosa M., Rumi D.O., et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord 2005, 20:1178-1184.
18. Introduction to Meta-Analysis 2008, Wiley Publications, New York. M. Bornstein, L. Hedges, J. Higgins, H. Rothstein (Eds.).
19. Shuster J.J. Empirical vs natural weighting in random effects meta-analysis. Stat Med 2010, 29:1259-1265.
20. Shuster J.J., Guo J.D., Skyler J.S. Meta-analysis of safety for low event-rate binomial trials. Res Synth Methods 2012, 3:30-50.
21. Phillips B, Ball C, Sackett D. Levels of evidence and grades of recommendations Available at Accessed July 11, 2011. http://www.cebm.net/.
22. Maher C.G., Sherrington C., Herbert R.D., Moseley A.M., Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003, 83:713-721.
23. Okabe S., Ugawa Y., Kanazawa I. Effectiveness of rTMS on Parkinson's Disease Study Group. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease. Mov Disord 2003, 18:382-388.
24. Khedr E.M., Farweez H.M., Islam H. Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patients. Eur J Neurol 2003, 10:567-572.
25. Lefaucheur J.P., Drouot X., Von Raison F., Menard-Lefaucheur I., Cesaro P., Nguyen J.P. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin Neurophysiol 2004, 115:2530-2541.
26. Lomarev M.P., Kanchana S., Bara-Jimenez W., Iyer M., Wassermann E.M., Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 2006, 21:325-331.
27. Filipovic S.R., Rothwell J.C., Bhatia K. Slow (1 Hz) repetitive transcranial magnetic stimulation (rTMS) induces a sustained change in cortical excitability in patients with Parkinson's disease. Clin Neurophysiol 2010, 121:1129-1137.
28. Pal E., Nagy F., Aschermann Z., Balazs E., Kovacs N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study. Mov Disord 2010, 25:2311-2317.
29. Arias P., Vivas J., Grieve K.L., Cudeiro J. Controlled trial on the effect of 10 days low-frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's disease. Mov Disord 2010, 25:1830-1838.
30. del Olmo M.F., Bello O., Cudeiro J. Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease. Clin Neurophysiol 2007, 118:131-139.
31. Dragasevic N., Potrebic A., Damjanovic A., Stefanova E., Kostic V.S. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: An open study. Mov Disord 2002, 17:528-532.
32. Buhmann C., Gorsler A., Baumer T., Hidding U., Demiralay C., Hinkelmann K., et al. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. Brain 2004, 127(Pt 12):2732-2746.
33. Baumer T., Hidding U., Hamel W., Buhmann C., Moll C.K., Gerloff C., et al. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease. Mov Disord 2009, 24:672-676.
34. Benninger D.H., Lomarev M., Wassermann E.M., Lopez G., Houdayer E., Fasano R.E., et al. Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease. Clin Neurophysiol 2009, 120:809-815.
35. Shimamoto H., Takasaki K., Shigemori M., Imaizumi T., Ayabe M., Shoji H. Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson's disease. J Neurol 2001, 248(Suppl 3):III48-52.
36. Ikeguchi M., Touge T., Nishiyama Y., Takeuchi H., Kuriyama S., Ohkawa M. Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson's disease. J Neurol Sci 2003, 209:41-46.
37. Siebner H.R., Rossmeier C., Mentschel C., Peinemann A., Conrad B. Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's disease. J Neurol Sci 2000, 178:91-94.
38. Fregni F., Santos C.M., Myczkowski M.L., Rigolino R., Gallucci-Neto J., Barbosa E.R., et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004, 75:1171-1174.
39. Mir P., Matsunaga K., Gilio F., Quinn N.P., Siebner H.R., Rothwell J.C. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease. Neurology 2005, 64:1906-1912.
40. Sedlackova S., Rektorova I., Srovnalova H., Rektor I. Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson's disease. J Neural Transm 2009, 116:1093-1101.
41. Khedr E.M., Rothwell J.C., Shawky O.A., Ahmed M.A., Hamdy A. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord 2006, 21:2201-2205.
42. Koch G., Brusa L., Caltagirone C., Peppe A., Oliveri M., Stanzione P., et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology 2005, 65:623-625.
43. Brusa L., Versace V., Koch G., Iani C., Stanzione P., Bernardi G., et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clin Neurophysiol 2006, 117:1917-1921.
44. Wagle-Shukla A., Angel M.J., Zadikoff C., Enjati M., Gunraj C., Lang A.E., et al. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology 2007, 68:704-705.
45. Filipovic S.R., Rothwell J.C., van de Warrenburg B.P., Bhatia K. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease. Mov Disord 2009, 24:246-253.
46. Sommer M., Paulus W. Pulse configuration and rTMS efficacy: A review of clinical studies. Suppl Clin Neurophysiol 2003, 56:33-41.
47. Pascual-Leone A., Tormos J.M., Keenan J., Tarazona F., Canete C., Catala M.D. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol 1998, 15:333-343.
48. Wu A.D., Fregni F., Simon D.K., Deblieck C., Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics 2008, 5:345-361.
49. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 1995, 118:913-933.
50. Shulman L.M., Gruber-Baldini A.L., Anderson K.E., Fishman P.S., Reich S.G., Weiner W.J. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 2010, 67:64-70.
51. Rossi S., Ferro M., Cincotta M., Ulivelli M., Bartalini S., Miniussi C., et al. A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS). Clin Neurophysiol 2007, 118:709-716.
52. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120:2008-2039.